These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19027875)

  • 1. Perispinal etanercept for neuroinflammatory disorders.
    Tobinick E
    Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perispinal etanercept: a new therapeutic paradigm in neurology.
    Tobinick E
    Expert Rev Neurother; 2010 Jun; 10(6):985-1002. PubMed ID: 20518613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
    Tobinick E; Davoodifar S
    Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
    Tobinick EL; Gross H
    J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perispinal etanercept for treatment of Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.
    Tobinick E
    CNS Drugs; 2009 Sep; 23(9):713-25. PubMed ID: 19689163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
    Tobinick EL; Gross H
    BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perispinal etanercept: potential as an Alzheimer therapeutic.
    Griffin WS
    J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
    Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
    CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate neurological recovery following perispinal etanercept years after brain injury.
    Tobinick E; Rodriguez-Romanacce H; Levine A; Ignatowski TA; Spengler RN
    Clin Drug Investig; 2014 May; 34(5):361-6. PubMed ID: 24647830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Centorrino T; Siriwardena AK; Cuzzocrea S
    Shock; 2007 May; 27(5):542-51. PubMed ID: 17438460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
    Tobinick E
    Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats.
    Norimoto M; Ohtori S; Yamashita M; Inoue G; Yamauchi K; Koshi T; Suzuki M; Orita S; Eguchi Y; Sugiura A; Ochiai N; Takaso M; Takahashi K
    Spine (Phila Pa 1976); 2008 Oct; 33(22):2403-8. PubMed ID: 18824950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
    Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
    Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.
    Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF
    Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perispinal TNF-alpha inhibition for discogenic pain.
    Tobinick EL; Britschgi-Davoodifar S
    Swiss Med Wkly; 2003 Mar; 133(11-12):170-7. PubMed ID: 12715286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
    Tobinick E
    CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal production of tumor necrosis factor (TNF) -- alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected].
    Cortis E; De Benedetti F; Insalaco A; Cioschi S; Muratori F; D'Urbano LE; Ugazio AG
    J Pediatr; 2004 Dec; 145(6):851-5. PubMed ID: 15580218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
    Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
    J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.